313 related articles for article (PubMed ID: 32846789)
1. A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer.
Li C; Wang L; Wu Q; Zhao J; Yi F; Xu J; Wei Y; Zhang W
Medicine (Baltimore); 2020 Aug; 99(34):e21715. PubMed ID: 32846789
[TBL] [Abstract][Full Text] [Related]
2. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
Watanabe K; Katsui K; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
Radiat Oncol; 2021 Feb; 16(1):39. PubMed ID: 33622369
[TBL] [Abstract][Full Text] [Related]
3. SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC.
Nyman J; Hallqvist A; Lund JÅ; Brustugun OT; Bergman B; Bergström P; Friesland S; Lewensohn R; Holmberg E; Lax I
Radiother Oncol; 2016 Oct; 121(1):1-8. PubMed ID: 27600155
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacy of stereotactic body radiotherapy and thoracoscopic surgery in the treatment of early-stage non-small cell lung cancer.
Li X; Niu C; Chen Q; Chen X
J BUON; 2020; 25(3):1497-1503. PubMed ID: 32862596
[TBL] [Abstract][Full Text] [Related]
5. Prior Treatment for Non-small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy: A Retrospective Multivariate and Matched Pair Analysis.
Farrugia MK; Jun Ma S; Hennon MW; Nwogu CE; Dexter EU; Picone AL; Demmy TL; Gomez-Suescun JA; Fung-Kee-Fung S; Yendamuri SS; Singh AK
Am J Clin Oncol; 2021 Jan; 44(1):18-23. PubMed ID: 33264123
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
7. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
Schonewolf CA; Heskel M; Doucette A; Singhal S; Frick MA; Xanthopoulos EP; Corradetti MN; Friedberg JS; Pechet TT; Christodouleas JP; Levin W; Berman A; Cengel KA; Verma V; Hahn SM; Kucharczuk JC; Rengan R; Simone CB
Clin Lung Cancer; 2019 Jan; 20(1):e63-e71. PubMed ID: 30337269
[TBL] [Abstract][Full Text] [Related]
8. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.
Kann BH; Verma V; Stahl JM; Ross R; Dosoretz AP; Shafman TD; Gross CP; Park HS; Yu JB; Decker RH
Radiother Oncol; 2019 May; 134():44-49. PubMed ID: 31005223
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
[TBL] [Abstract][Full Text] [Related]
11. Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC).
Lucas JT; Kuremsky JG; Soike M; Hinson WW; Kearns WT; Hampton CJ; Blackstock AW; Urbanic J
Lung Cancer; 2014 Jul; 85(1):59-65. PubMed ID: 24813936
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy for medically inoperable early-stage lung cancer: Tata Memorial Hospital perspective and practice recommendations.
Agarwal JP; Pilar A; Mummudi N; Gupta M; Laskar SG; Pathak RS; Tibdewal AR; Kinhikar R; Ghadi Y; Tandon S; Purandare N; Prabhash K; Patil V
Indian J Cancer; 2020; 57(1):18-24. PubMed ID: 31929233
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta - A population-based study.
Liu HW; Gabos Z; Ghosh S; Roberts B; Lau H; Kerba M
Radiother Oncol; 2015 Oct; 117(1):71-6. PubMed ID: 26349589
[TBL] [Abstract][Full Text] [Related]
14. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA
Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
Kann BH; Miccio JA; Stahl JM; Ross R; Verma V; Dosoretz AP; Park HS; Shafman TD; Gross CP; Yu JB; Decker RH
Radiother Oncol; 2019 Mar; 132():188-196. PubMed ID: 30391106
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
[TBL] [Abstract][Full Text] [Related]
17. One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 Trial.
Singh AK; Gomez-Suescun JA; Stephans KL; Bogart JA; Hermann GM; Tian L; Groman A; Videtic GM
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):752-759. PubMed ID: 31445956
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early-stage non-small cell lung cancer.
Shu Z; Dong B; Shi L; Shen W; Hang Q; Wang J; Chen Y
J Cancer Res Clin Oncol; 2020 May; 146(5):1263-1271. PubMed ID: 32095885
[TBL] [Abstract][Full Text] [Related]
19. Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients.
Mancini BR; Park HS; Harder EM; Rutter CE; Corso CD; Decker RH; Husain ZA
Lung Cancer; 2016 Jul; 97():22-7. PubMed ID: 27237023
[TBL] [Abstract][Full Text] [Related]
20. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80years old): Extremely safe and effective.
Kreinbrink P; Blumenfeld P; Tolekidis G; Sen N; Sher D; Marwaha G
J Geriatr Oncol; 2017 Sep; 8(5):351-355. PubMed ID: 28739159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
